Last reviewed · How we verify

NCT05898880

The Effect of Acupressure on Pain, Nausea-Vomiting, and Mental Well-Being in Oncology Patients

Status unknown NA Last updated 12 June 2023
What this trial tests

NA trial testing Self-acupressure in Pain in 93 participants. Status unknown.

Timeline
5 June 2023
Primary endpoint
31 July 2023
24 August 2023

Quick facts

Lead sponsorMersin University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment93
Start date5 June 2023
Primary completion31 July 2023
Estimated completion24 August 2023

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

18 and older, any sex, with Pain or Nausea With Vomiting Chemotherapy-Induced. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the effect of self acupressure and acupressure applied by therapists on pain, nausea-vomiting, and mental well-being in oncology patients. For this purpose, 93 individuals with stage 1-stage 3 cancer will be included in the study. The main questions it aims to answer are: • Is acupressure effective on pain, nausea-vomiting and mental well-being in oncology patients? Is there a difference in the effectiveness of self-acupressure and acupressure applied by therapist on pain, nausea-vomiting and mental well-being? The participants will be included in the study as three groups, namely the self-acupressure group, the acupressure group applied by the therapist, and the control group. Self-acupressure participants will self-administer acupressure. In the acupressure group, which will be applied by the therapist, acupressure will be applied to the participants by researchers who have acupressure certificate. In the control group, acupressure etc. No additional application will be made. Visual analog scale, nausea-vomiting and retching index, and mental well-being scales will be applied to all groups at the beginning of the study and three days after the study.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications.
    Li K, Guo B, Gu J, Ta N, et al · · 2025 · cited 8× · PMID 39759851 · DOI 10.1016/j.mtbio.2024.101375

Verify or expand the search:

Other trials of Self-acupressure

Trials testing the same drug.

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05898880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing